If today’s hearing was any indication, Dr. Eric Goosby is headed for an easy confirmation to be U.S. Global AIDS Coordinator. Dr. Goobsy’s time in the hot seat, before the Senate Foreign Relations Committee, lasted all of 30 minutes this afternoon, and he wasn’t thrown any hardballs. In his opening remarks, Dr. Goosby talked about […]
In a significant development, the National Institute of Allergy and Infectious Diseases announced that it a trial in Haiti–investigating the impact of earlier ART therapy in HIV-positive patients—would be ended early because the results were overwhelming; the findings showed that HIV-infected adults are more likely to survive if they start antiretroviral drugs before their immune […]
For anyone interested in the fight against global AIDS, today is potentially pivotal. This afternoon, the Senate Foreign Relations Committee will hold a confirmation hearing on Dr. Eric Goosby’s nomination to be U.S. Global AIDS Coordinator. A full Senate vote confirming Goosby cannot come too soon; with Congress set to make funding decisions in the […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]